InvestorsHub Logo
Followers 91
Posts 11390
Boards Moderated 0
Alias Born 06/06/2014

Re: farrell90 post# 243738

Thursday, 10/04/2018 3:12:33 PM

Thursday, October 04, 2018 3:12:33 PM

Post# of 403222
The inclusion of IBD in licensing negotiations was a very welcome bit of news. Frankly it was a head scratcher why it was 'omitted' in the first announcement (which just mentioned OM), since both are GI tract anti-inflammatory indications and a licensee should naturally want both.
Looking out for that deal announcement.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News